Effects of lasofoxifene and bazedoxifene on B cell development and function

被引:28
作者
Bernardi, Angelina I. [1 ]
Andersson, Annica [1 ]
Grahnemo, Louise [1 ]
Nurkkala-Karlsson, Merja [1 ]
Ohlsson, Claes [2 ]
Carlsten, Hans [1 ]
Islander, Ulrika [1 ]
机构
[1] Gothenburg Univ, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Dept Rheumatol & Inflammat Res, Box 480, S-40530 Gothenburg, Sweden
[2] Gothenburg Univ, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Antibody production; B cell development; estrogen; mouse; SERMs;
D O I
10.1002/iid3.37
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The third generation selective estrogen receptor modulators lasofoxifene (las) and bazedoxifene (bza) are indicated for treatment of postmenopausal osteoporosis. 17 beta-Estradiol (E2) and the second generation SERM raloxifene (ral) have major effects on the immune system, particularly on B cells. Treatment with E2 or ral inhibits B lymphopoiesis and treatment with E2, but not ral, stimulates antibody production. The effects of las and bza on the immune system have not been studied. Therefore, the aim of this study was to investigate their role in B cell development, maturation, and function. C57BL/6 mice were sham-operated or ovariectomized (ovx) and treated with vehicle, E2, ral, las, or bza. All substances increased total bone mineral density in ovx mice, as measured by peripheral quantitative computed tomography. In uterus, bza alone lacked agonistic effect in ovx mice and even acted as an antagonist in sham mice. As expected, E2 decreased B cell numbers at all developmental stages from pre-BI cells (in bone marrow) to transitional 1 (T1) B cells (in spleen) and increased marginal zone (MZ) B cells as determined by flow cytometry. However, treatment with las or bza only decreased the last stages of bone marrow B cell development and splenic T1 B cells, but had no effect MZ B cells. E2 increased antibody-producing cells quantified by ELISPOT, but las or bza did not. In conclusion, las and bza differ from E2 by retaining normal number of cells at most B cell stages during B lymphopoiesis and maturation and by not increasing antibody-producing cells.
引用
收藏
页码:214 / 225
页数:12
相关论文
共 45 条
[1]   Hormone replacement therapy, heart disease, and other considerations [J].
Barrett-Connor, E ;
Grady, D .
ANNUAL REVIEW OF PUBLIC HEALTH, 1998, 19 :55-72
[2]   BAFF mediates survival of peripheral immature B lymphocytes [J].
Batten, M ;
Groom, J ;
Cachero, TG ;
Qian, F ;
Schneider, P ;
Tschopp, J ;
Browning, JL ;
Mackay, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1453-1465
[3]   Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells [J].
Bynoe, MS ;
Grimaldi, CM ;
Diamond, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2703-2708
[4]   ESTROGEN ACCELERATES IMMUNE-COMPLEX GLOMERULONEPHRITIS BUT AMELIORATES T-CELL-MEDIATED VASCULITIS AND SIALADENITIS IN AUTOIMMUNE MRL LPR/LPR MICE [J].
CARLSTEN, H ;
NILSSON, N ;
JONSSON, R ;
BACKMAN, K ;
HOLMDAHL, R ;
TARKOWSKI, A .
CELLULAR IMMUNOLOGY, 1992, 144 (01) :190-202
[5]   Control of peripheral B-cell development [J].
Casola, Stefano .
CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (02) :143-149
[6]   Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling [J].
Clark, Marcus R. ;
Mandal, Malay ;
Ochiai, Kyoko ;
Singh, Harinder .
NATURE REVIEWS IMMUNOLOGY, 2014, 14 (02) :69-80
[7]  
D'Elia HF, 2003, J RHEUMATOL, V30, P1456
[8]   B cell antigen receptor signaling 101 [J].
Dal Porto, JM ;
Gauld, SB ;
Merrell, KT ;
Mills, D ;
Pugh-Bernard, AE ;
Cambier, J .
MOLECULAR IMMUNOLOGY, 2004, 41 (6-7) :599-613
[9]   Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice [J].
Erlandsson, MC ;
Jonsson, CA ;
Islander, U ;
Ohlsson, C ;
Carlsten, H .
IMMUNOLOGY, 2003, 108 (03) :346-351
[10]   Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice [J].
Erlandsson, MC ;
Jonsson, CA ;
Lindberg, MK ;
Ohlsson, C ;
Carlsten, H .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (02) :319-327